The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials.

Diabetol Metab Syndr · 2023 · PMC10369734 · PMID 37491292

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Meanwhile, GLP-1RAs showed a trend towards a reduced risk for nine respiratory diseases, although not reaching statistical significance, including pneumonia (RR 0.89, 95% CI 0.78–1.00, p = 0.05; I 2 = 0; Additional file 1 : Fig S5), Pulmonary fibrosis (RR 0.39, 95% CI 0.13–1.16, p = 0.09; I 2 = 0; Additional file 1 : Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.